68Ga-NB-381

N/A

Report date: 2025/09/19 17:44:58

Base Information

Drug Name68Ga-NB-381

Drug Alias Name68Ga-NB38168Ga-NB-38118F-FDG(The First Affiliated Hospital Of Beijing University)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Radiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[4]

Mechanisms of ActionPositron-emission tomography enhancersAnti-CD38

TargetsLymphocyte differentiation antigen CD38

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesThe First Affiliated Hospital Of Beijing University

China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Beijing University

Inactive CompaniesN/A

Active IndicationsMultiple Myeloma

Inactive IndicationsN/A

Other Information

ATC CodeN/A